logo
Dark
logo
Adult ADHD
Dark
ADHD Medication Meta-analysis
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults (Review)
Atomoxetine in ADHD Patients who use Marijuana
Do individuals with ADHD become more disinhibited with alcohol?
The Prevalence and Correlates of Adult ADHD in the United States: Results From the National Comorbidity Survey Replication
Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder
Comorbidity in adults with attention-deficit hyperactivity disorder
Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies
Adult ADHD & MRI
ADHD and Executive Function
Persistent ADHD Risk Factors
Does adult ADHD start during childhood?
Evidence for late onset ADHD
ADHD remission patterns in young adults
Persistent and late onset ADHD
Predictors of ADHD persistence in adulthood
Socioeconomic status and ADHD risk
Which symptoms resolve first in ADHD?
ADHD: Working Memory and Alpha Waves
Fitness and Executive Function in ADHD
Dopamine Receptors and ADHD
Anxiety, ADHD, and Cognitive Functioning
Executive functioning in adult ADHD: a meta-analytic review
ADHD Symptoms and Emotional Intelligence
ADHD, Attention, and Task Switching
Dopamine and Motivation in ADHD
ADHD, working memory, and verbal learning
ADHD and Forgetting
Sluggish Cognitive Tempo, ADHD, and Mind-Wandering
Medication and Training for Working Memory in ADHD
Long-Term Memory Performance in Adult ADHD
ADHD Symptoms and the Reward System
ADHD in high IQ adults
Can IQ compensate for ADHD symptoms?
IQ and ADHD have separate genetics
How ADHD and Test Taking Speed Affect Intelligence Testing
How IQ Compensates for ADHD in Executive Function
ADHD and estimated life expectancy
Irritability in ADHD
ADHD prevalence among adults with substance use disorder
Driving Anger and Driving Behavior in Adults With ADHD
Adult ADHD and Employment Stats
ADHD among adult workers
Maladaptive Daydreaming and Mental Health
Emotion dysregulation in adults with attention deficit hyperactivity disorder: a meta-analysis
ADHD and Comorbidity Statistics
ADHD and Empathy in Adults
Effects of ADHD in Parents
How do people with ADHD handle emotions?
Daydreaming and Attention in ADHD
Self-Esteem, Self-Efficacy, and Resources in Adults With ADHD
ADHD and Adjusting to College Life
ADHD, Executive Function, and Employment
ADHD and Anxiety: Clinical Significance and Treatment Implications
Vitamins, Minerals, and ADHD
Ritalin and Driving Ability
Does Ritalin improve your driving?
ADHD and Driving in Young Adults
Is Ritalin or Adderall better for driving?
Driving with ADHD and Alcohol
Do non-stimulant medications work for adult ADHD?
Ritalin: The effects of gender and alcohol
Ritalin reduces anxiety in cognitive test
Ritalin, reaction time, and response inhibition in healthy adults
Guanfacine vs Adderall for Adult ADHD
Venlafaxine for Adult ADHD
Ritalin may reduce anxiety in anxious adults without ADHD
Group CBT for Adult ADHD
Does CBT work well with medication for Adult ADHD?
CBT vs. Relaxation for Adult ADHD
ADHD and Skills Training Therapy
Mindfulness vs psychoeducation in adult ADHD: a randomized controlled trial
ADHD Psychotherapy and Skills Training
Structured Group Psychotherapy for ADHD
Efficacy of Meta-Cognitive Therapy (MCT) for Adult ADHD
Mindfulness CBT for ADHD
ADHD Medication and Blood Pressure
Working Memory and College Performance
Ritalin, Adderall, and Risks in Pregnancy
Atomoxetine in Adults with ADHD: Two Randomized, Placebo-Controlled Studies
Once-Daily Atomoxetine for Adult Attention-Deficit/Hyperactivity Disorder
Emotional dysregulation in adult ADHD and response to atomoxetine
Can you drink alcohol with Strattera (atomoxetine)?
Strattera and Social Anxiety in Adults
Effects of stimulants and atomoxetine on emotional lability in adults: A systematic review and meta-analysis
Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders
ADHD Meds & Heart Risk in Adults
Does Ritalin increase the risk of mania in those with Bipolar Disorder?
How often do teenagers use stimulants with other substances?
Irritability with Stimulants
Stimulant Medication and Substance Use Outcomes: A Meta-analysis

Evidence Based Answers

Once-Daily Atomoxetine for Adult Attention-Deficit/Hyperactivity Disorder

November 2, 2022
💊
Strattera is a non-stimulant medication used to treat ADHD.
☀️
At first, it was only given twice a day. This study looked to see whether it could also be given once a day in the morning.
🌖
Researchers found that once-a-day dosing was effective in treating ADHD, with improvements lasting into the evening.

Once Daily Strattera for Adult ADHD
Once-Daily Atomoxetine for Adult Attention-Deficit/Hyperactivity Disorder: A 6-Month, Double-Blind Trial

Introduction

This study aimed to test whether Strattera given once a day, instead of twice a day, could effectively reduce ADHD symptoms in adults.

Researchers had previous established that Strattera twice a day works in adults.

This paper helped establish the effectiveness of once-a-day Strattera in adults, and provided valuable data to help us further understand the effects of Strattera.

Study Quote
Adler, 2009 J. Clin. Psychopharm.

This randomized, double-blind, placebo-controlled, 6-month trial examined the efficacy and safety of once-daily morning-dosed atomoxetine in adult patients with attention-deficit/hyperactivity disorder (ADHD) and the efficacy of atomoxetine in ameliorating symptoms through the evening ho...

Show More

Methods

Researchers randomly selected patients to receive either Strattera or a placebo control. They measured the effectiveness of the medication by testing participants for ADHD symptoms and quality of life before and after the treatment.

Results

Study Quote
Adler, 2009 J. Clin. Psychopharm.

Overall, 94 patients randomized to atomoxetine and 112 patients randomized to placebo completed the study. On the AISRS total score, Conners' Adult ADHD Rating Scale-Investigator Rated: Screening Version evening index total score, Clinical Global Impressions-ADHD-Severity of Illness scor...

Show More

94 volunteers given Strattera and 112 given a placebo control completed the study. Those given Strattera had a higher quality of life and fewer ADHD symptoms than those given the control.

At 6 months, the chart below shows that those given Strattera had significantly greater symptom reduction than those given the control.

These data suggest that once-a-day Strattera can effectively reduce ADHD symptoms in adults.

ADHD Symptom Reduction among 501 adults, including 250 given once-daily Strattera
Study Quote
Adler, 2009 J. Clin. Psychopharm.

Nausea, dry mouth, fatigue, decreased appetite, urinary hesitation, and erectile dysfunction were the treatment-emergent adverse events reported significantly more often with atomoxetine. Discontinuations due to adverse events were 17.2% and 5.6% for atomoxetine and placebo, respectively...

Show More

There were side effects found in the study.

Overall, 17.2% of those on Strattera left the study due to side effects, compared to 5.6% of those given the placebo control.

This suggests that for some, Strattera can cause notable side effects.

The most common side effects were nausea, dry mouth, fatigue, and decreased appetite. All of these side effects were significantly more common in the treatment group than the control group.

Conclusions

Based on the data above, researchers concluded that Strattera given once a day can effectively reduce ADHD symptoms throughout the entire day.

Study Quote
Adler, 2009 J. Clin. Psychopharm.

Once-daily morning-dosed atomoxetine is efficacious for treating ADHD in adults when measured 10 weeks and 6 months after initiating treatment. Atomoxetine demonstrated significant efficacy that continued into the evening. Adverse events were similar to previous trials.